Re:Special Incentive Bonus AgreementSpecial Incentive Bonus Agreement • February 14th, 2023 • iBio, Inc. • Pharmaceutical preparations • Texas
As you are aware, iBio, Inc., a Delaware corporation (the “Company”), is currently in the process of selling its manufacturing facility and transforming into a biopharmaceutical discovery and development company solely focused on immune-oncology (the “Transformation”). We are grateful for your dedication and service to the Company and trust you will provide highly valued assistance in both making this Transformation a success and in achieving the Company’s 2023 objectives.
Re:Special Incentive Bonus AgreementSpecial Incentive Bonus Agreement • February 14th, 2023 • iBio, Inc. • Pharmaceutical preparations • California
As you are aware, iBio, Inc., a Delaware corporation (the “Company”), is currently in the process of selling its manufacturing facility and transforming into a biopharmaceutical discovery and development company solely focused on immune-oncology (the “Transformation”). We are grateful for your dedication and service to the Company and trust you will provide highly valued assistance in both making this Transformation a success and in achieving the Company’s 2023 objectives.
SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • February 14th, 2023 • iBio, Inc. • Pharmaceutical preparations • Texas
THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Second Amendment”) is entered into as of the Second Amendment Closing Date (as defined below) by and between IBIO CDMO LLC, a Delaware limited liability company (“Borrower”), and WOODFOREST NATIONAL BANK, a national banking association, as lender (in such capacity, “Lender”).
